executive vice president of the thrombosis business unit at Leo, added details about how his team will handle the product, explaining that the drug complements the company’s “existing heparin ...
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
LEO Pharma will make payments ... areas of high unmet medical need and focuses on a specialty hospital product that complement our existing heparin-based anti-coagulation treatments for ...
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
LEO Pharma will make payments ... need and focuses on a specialty hospital product that complement our existing heparin-based anti-coagulation treatments for cancer-associated thrombosis and ...
LEO Pharma will manage the distribution ... focuses on a speciality hospital product that complements our existing heparin-based anti-coagulation treatments for cancer-associated thrombosis ...
LEO Pharma will manage the distribution ... of high unmet medical need and focuses on a speciality hospital product that complements our existing heparin-based anti-coagulation treatments for ...
Publicis Groupe has announced that Leo Burnett and Publicis Worldwide will merge to form Leo in more than 90 countries with some 15,000 staff—though in Australia it’s simply a rebrand.
Between Groundhog Day’s prediction for 6 more weeks of winter and the recent cold fronts rushing into both northern and ...
Publicis Groupe has merged creative networks Publicis Worldwide and Leo Burnett to form new creative unit Leo, per a press release. Leo includes about 8,000 creative employees from Leo Burnett and ...
Are you a print subscriber? Activate your account. By Lindsay Rittenhouse - 9 hours 12 min ago By Garett Sloane - 22 hours 29 min ago By Lindsay Rittenhouse - 22 hours 50 min ago 1 day ago By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results